Elanco Animal Health Incorporated
ELANNYSEHealthcare● Active
$23.80
+$0.17(+0.70%)
Market Cap$11.9B
P/E Ratio—
52W High$27.72
52W Low$13.16
Elanco Animal Health Incorporated (ELAN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ELAN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B |
| Cost of Revenue | $2.67B | $2.53B | $2.48B | $2.44B | $2.69B |
| Gross Profit | $2.05B | $1.91B | $1.94B | $1.97B | $2.08B |
| Gross Margin %(computed) | 43.48% | 43.01% | 43.88% | 44.66% | 43.58% |
| Operating Expenses | |||||
| R&D Expenses | $0.37B | $0.34B | $0.33B | $0.32B | $0.37B |
| G&A Expenses | $0.00B | $1.07B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $1.80B | $1.66B | $1.61B | $1.59B | $1.77B |
| Operating Income | $0.25B | $0.25B | $0.33B | $0.38B | $0.30B |
| Operating Margin %(computed) | 5.34% | 5.65% | 7.38% | 8.71% | 6.38% |
| Interest Income | $0.04B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.22B | $0.34B | $0.28B | $0.26B | $0.26B |
| Income Before Tax | ($0.22B) | $0.49B | ($1.20B) | ($0.07B) | ($0.57B) |
| Income Tax Expense | $0.01B | $0.15B | $0.04B | $0.01B | ($0.09B) |
| Net Income | ($0.23B) | $0.34B | ($1.23B) | ($0.08B) | ($0.48B) |
| Net Margin %(computed) | -4.92% | 7.61% | -27.87% | -1.77% | -10.14% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.47 | $0.68 | $-2.50 | $-0.15 | $-0.97 |
| Wtd Avg Shares | 0.50B | 0.49B | 0.49B | 0.49B | 0.49B |
| EBITDA | $0.68B | $1.49B | ($0.22B) | $0.87B | $0.41B |
| EBITDA Margin %(computed) | 14.34% | 33.54% | -5.07% | 19.63% | 8.59% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Elanco Animal Health Incorporated data
About Elanco Animal Health Incorporated (ELAN) Income Statement
Elanco Animal Health Incorporated (ELAN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ELAN reported revenue of $4.71B, gross profit of $2.05B (gross margin 43.48%), and net income of ($0.23B) — a net profit margin of -4.92%.
Frequently asked questions
ELAN · 4 questionsElanco Animal Health Incorporated (ELAN) reported revenue of $4.71B for 2025, up 6.2% year-over-year.
ELAN revenueELAN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08